Nartussal (NARTEX LABORATORIOS HOMEOPATICOS SA DE CV)


Welcome to the PulseAid listing for the Nartussal drug offered from NARTEX LABORATORIOS HOMEOPATICOS SA DE CV. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: NARTEX LABORATORIOS HOMEOPATICOS SA DE CV
NON-PROPRIETARY NAME: Bryonia alba, Drosera rotundifolia, Ipecacuanha
SUBSTANCE NAME: BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-07-25
END MARKETING DATE: 0000-00-00


Nartussal HUMAN OTC DRUG Details:

Item DescriptionNartussal from NARTEX LABORATORIOS HOMEOPATICOS SA DE CV
LABELER NAME: NARTEX LABORATORIOS HOMEOPATICOS SA DE CV
DEA SCHEDULE:
ACTIVE STRENGTH: 5; 5; 5([hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2011-07-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 34666-121_f844c322-0e2c-4918-8753-357e6eaee1a8
PRODUCT NDC: 34666-121
APPLICATION NUMBER:

Other BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
NARTEX LABORATORIOS HOMEOPATICOS SA DE CVNartussal